Jason Ryan

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Bridget Brown, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Ryan:

Form 4 holding Director

Singular Genomics Systems, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
$0
Report date
21 Feb 2025
Price
$8.84
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

SomaLogic, Inc.

Security class
Restricted Stock Unit (RSU)
Shares / value
0
Estimated value
Report date
05 Jan 2024
Price
$2.43
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

SomaLogic, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
05 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jason Ryan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .